Blaise, Didier <br/><br/>
Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia.  [electronic resource] 

 -  Haematologica  Apr 2007 
 - 533-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.10867  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antilymphocyte Serum--administration & dosage<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow Diseases--chemically induced<br/>Clinical Trials as Topic--statistics & numerical data<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Female<br/>Graft vs Leukemia Effect<br/>Hematopoietic Stem Cell Transplantation--mortality<br/>Humans<br/>Leukemia, Myeloid--drug therapy<br/>Lymphocyte Depletion<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Remission Induction<br/>Survival Analysis<br/>T-Lymphocytes<br/>Time Factors<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Vidarabine--administration & dosage